Atropine Sulfate
- Product NDC
- 71872-7255
- 11-digit product format
- 718727255
- Labeler code
- 71872
- Product ID
- 71872-7255_c8e868f6-315c-5540-e053-2a95a90a29e8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atropine Sulfate
- Dosage form
- INJECTION, SOLUTION
- Route
- ENDOTRACHEAL; INTRAMEDULLARY; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Medical Purchasing Solutions, LLC
- Application
- ANDA213424
- Marketing category
- ANDA
- Marketing start
- 2021-03-25
- Marketing end
- 0000-00-00
- Substance
- ATROPINE SULFATE
- Active strength
- 0 mg/mL
- Pharmacologic classes
- Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6c78bd43-efb4-4aeb-b7d8-eff1532f7822 | Product name | 4 | 20250801 |
| 41231c1e-8789-4da7-ac52-77fa90a85bf5 | Product name | 2 | 20250304 |
| e77ab9a2-80cf-4832-bff0-469bbc7cbcd0 | Product name | 2 | 20250214 |
| 5f84b7a7-523a-f042-dffb-1dadcd9b2407 | Product name | 4 | 20240110 |
| 0cbc6fb2-78c0-4b88-98f0-a4cc76ff95ca | Product name | 1 | 20230719 |
| 04cd5dc0-102f-46cb-8dbc-ca38dd2628d0 | Product name | 3 | 20230317 |
| dfd25202-b8d2-4628-9213-f3e0f9eafce5 | Product name | 4 | 20210513 |
| 4199bf9b-4718-828a-6dd6-ac2fbbd61687 | Product name | 1 | 20140508 |
| 4edd8af5-cea7-ae42-8023-e91c5335db1d | Product name | 1 | 20140508 |
| d3908afb-7784-440f-c406-88294732d36a | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 71872-7255-1 | 2023-01-30 | C162847 | 48780-1 | f386c649-b7ca-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE injection, for intravenous, intramuscular, subcutaneous, intraosseous or endotracheal use. Initial U.S. Approval: 1960 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71872-7255-1 | Atropine Sulfate | 1 in 1 BAG | INJECTION, SOLUTION | 1 | 1 | |
| 71872-7255-1 | Atropine Sulfate | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71872-7255 | ATROPINE SULFATE INJECTION, SOLUTION [MEDICAL PURCHASING SOLUTIONS, LLC] | 1 | Legacy NDC, 2 package rows | 20210808_c8e868f6-315b-5540-e053-2a95a90a29e8.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1190776 | atropine sulfate 0.4 MG/ML Injectable Solution | PSN | c8e868f6-315b-5540-e053-2a95a90a29e8 | 1 |
| 1190776 | atropine sulfate 0.4 MG/ML Injectable Solution | SCD | c8e868f6-315b-5540-e053-2a95a90a29e8 | 1 |
| 1190776 | atropine sulfate 1 MG per 2.5 ML Injectable Solution | SY | c8e868f6-315b-5540-e053-2a95a90a29e8 | 1 |
| 1190776 | atropine sulfate 1.2 MG per 3 ML Injectable Solution | SY | c8e868f6-315b-5540-e053-2a95a90a29e8 | 1 |
| 1190776 | atropine sulfate 2 MG per 5 ML Injectable Solution | SY | c8e868f6-315b-5540-e053-2a95a90a29e8 | 1 |
| 1190776 | atropine sulfate 8 MG per 20 ML Injectable Solution | SY | c8e868f6-315b-5540-e053-2a95a90a29e8 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 71872-7255-1 | 71872725501 | 1 CARTON in 1 BAG (71872-7255-1) > 1 VIAL, MULTI-DOSE in 1 CARTON > 20 mL in 1 VIAL, MULTI-DOSE | 1 carton | 2021-07-07 | 0000-00-00 | No | No | Current |